Sangamo Therapeutics (GBY.F) Q3 2025 Earnings

Aug 7Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.13
-0.07
-0.02
0.04

Details

Expected EPS
-0.00862057344
Actual EPS
-0.0685056
Surprise EPS
-0.06
Surprise Percent
-694.68%

Description

⁨Sangamo Therapeutics⁩ (⁦GBY.F⁩) has reported earnings of ⁦-0.0685056⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts